Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Adjuvant|Chemotherapy
Interventions: DRUG: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide|DRUG: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide
Sponsor: Fudan University